文献速递运动医学创伤骨科

新型丝纤维基前交叉韧带支架通过形成韧带-骨界面实现骨整合

Osteointegration of a Novel Silk Fiber-Based ACL Scaffold by Formation of a Ligament-Bone Interface.
PubMed 文献 · Am J Sports Med · 2019-01-17

本研究在33只羊体内评估新型丝纤维基前交叉韧带支架在股骨和胫骨隧道中的骨整合,并比较术中接种自体血管基质组分的效果。组织学显示所有组均形成胶原纤维中间区,部分为Sharpey纤维;微计算机断层扫描显示12个月时细胞接种组仅在胫骨隧道组织密度显著高于单纯支架组。作者结论认为该支架可实现类似自体/异体移植的整合,但细胞接种未在组织学上增强骨整合,且12个月时仍有大量丝线存留,需更长观察期。

要点

  • 所有治疗组均形成胶原纤维中间区,部分为Sharpey纤维,组织学上未见组间差异。
  • 12个月时细胞接种组胫骨隧道组织密度显著高于单纯支架组,股骨隧道无显著差异。
  • 6个月与12个月之间未检测到显著差异,12个月时仍有大量丝线存留。

核心结论

  • 新型丝纤维基前交叉韧带再生支架通过形成类似自体/异体移植的纤维中间区而整合入骨隧道。
  • 组织学上,额外细胞接种未增强骨整合。
  • 6个月与12个月之间未检测到显著差异。
  • 12个月时仍有大量丝线存留,需要更长观察期以确定是否形成真正的韧带-骨附着。

研究设计与样本

  • 受控实验室研究,33只羊行前交叉韧带切除后随机分入单纯支架组和细胞接种支架组。
  • 每组半数羊于术后6个月、半数于12个月处死,行硬组织组织学和微计算机断层扫描分析。

主要发现

  • 硬组织组织学显示所有治疗组(无论是否应用自体血管基质组分)在骨与丝基移植物之间均形成胶原纤维中间区。
  • 该胶原纤维连续性部分由Sharpey纤维构成,与自体/异体移植的腱-骨愈合相当。
  • 插入部位在6个月时基底较宽,12个月时更集中于轻微突出的骨结节样结构。
  • 组织学上治疗组间未检测到差异。
  • 微计算机断层扫描分析显示,植入12个月后细胞接种支架组在胫骨隧道组织密度显著高于单纯支架组,股骨隧道无显著差异。

临床怎么用

  • 作者认为,使用丝纤维基支架(联合或不联合额外细胞接种)进行前交叉韧带再生,可能为当前手术重建技术提供替代治疗选择。

局限性

  • 12个月时仍有大量丝线存留,需要更长观察期以确定是否形成真正的韧带-骨附着。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Given the unsatisfactory results and reported drawbacks of anterior cruciate ligament (ACL) reconstruction, such as donor site morbidity and the limited choice of grafts in revision surgery, new regenerative approaches based on tissue-engineering strategies are currently under investigation. PURPOSES: To determine (1) if a novel silk fiber-based ACL scaffold is able to initiate osteointegration in the femoral and tibial bone tunnels under in vivo conditions and (2) if the osteointegration process will be improved by intraoperatively seeding the scaffolds with the autologous stromal vascular fraction, an adipose-derived, stem cell-rich isolate from knee fat pads. STUDY DESIGN: Controlled laboratory study. METHODS: A total of 33 sheep underwent ACL resection and were then randomly assigned to 2 experimental groups: ACL reconstruction with a scaffold alone and ACL reconstruction with a cell-seeded scaffold. Half of the sheep in each group were randomly chosen and euthanized 6 months after surgery and the other half at 12 months. To analyze the integration of the silk-based scaffold in the femoral and tibial bone tunnels, hard tissue histology and micro-computed tomography measurements were performed. RESULTS: Hard tissue histological workup showed that in all treatment groups, with or without the application of the autologous stromal vascular fraction, an interzone of collagen fibers had formed between bone and silk-based graft. This collagen-fiber continuity partly consisted of Sharpey fibers, comparable with tendon-bone healing known for autografts and allografts. Insertion sites were more broad based at 6 months and more concentrated on the slightly protruding, bony knoblike structures at 12 months. Histologically, no differences between the treatment groups were detectable. Analysis of micro-computed tomography measurements revealed a significantly higher tissue density for the cell-seeded scaffold group as compared with the scaffold-alone group in the tibial but not femoral bone tunnel after 12 months of implantation. CONCLUSION: The novel silk fiber-based scaffold for ACL regeneration demonstrated integration into the bone tunnels via the formation of a fibrous interzone similar to allografts and autografts. Histologically, additional cell seeding did not enhance osteointegration. No significant differences between 6 and 12 months could be detected. After 12 months, there was still a considerable amount of silk present, and a longer observation period is necessary to see if a true ligament-bone enthesis will be formed. CLINICAL RELEVANCE: ACL regeneration with a silk fiber-based scaffold with and without additional cell seeding may provide an alternative treatment option to current techniques of surgical reconstruction.

来源:Am J Sports Med,查看原文。版权归原作者所有。

引用

  1. Teuschl AH, Tangl S, Heimel P, et al. Osteointegration of a Novel Silk Fiber-Based ACL Scaffold by Formation of a Ligament-Bone Interface. Am J Sports Med. 2019. PMID: 30653344. doi:10.1177/0363546518818792

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。